BLUDIGO
Live / Registered — Registered (as of 02 Apr 2024)
What this means for you
Registered since 02 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97267309
- Registration number
- 7347784
- Mark type
- Stylized text
- Filed
- 15 Feb 2022
- Published for opposition
- 07 Feb 2023
- Registered
- 02 Apr 2024
- Attorney of record
- Aaron Y. Silverstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations in the nature of indigo carmine solutions for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological systems by instillation, injection or local application; chemical preparations in the nature of indigo carmine for medical use for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological systems by instillation, injection or local application; chemical preparations in the nature of indigo carmine solutions for medical use for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological systems by instillation, injection or local application; indigo carmine solutions for use as a marker during gastro-intestinal endoscopy; indigo carmine solutions used as a contrast solution for medical imaging procedures; indigo carmine solutions for medical diagnostic purposes for viewing and marking tissue; indigo carmine solutions used as an aid in visualization of topographic irregularities and in delineation of polypoid or flat lesions, including adenomas; indigo carmine solutions used for polyps or lesions resection medicines for tissue staining; indigo carmine solutions for use as a marker during visceral surgery; indigo carmine solutions for the detection of amniotic fluid leaks; indigo carmine solutions for use as a marker during cystoscopy and ureteral catheterization; indigo carmine solutions for use as a marker during vessel delineation and tumor localization procedures; clinical medical reagents; diagnostic preparations in vials for medical use; drug delivery agents in the form of filled vials that facilitate the delivery of pharmaceutical preparations
Owner
- PROVEPHARM LIFE SOLUTIONS, Marseille, FR
- PROVEPHARM LIFE SOLUTIONS, Marseille, FR
- PROVEPHARM LIFE SOLUTIONS, Marseille, FR
Prosecution history
- 02 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 29 Feb 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Feb 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Feb 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Feb 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Feb 2024 — ASSIGNED TO LIE
- 05 Oct 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Aug 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Aug 2023 — NON-FINAL ACTION E-MAILED
- 16 Aug 2023 — SU - NON-FINAL ACTION - WRITTEN
- 07 Jun 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 11 May 2023 — USE AMENDMENT FILED
- 05 Jun 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 May 2023 — TEAS STATEMENT OF USE RECEIVED